Plunkett Research Online: Nabriva Therapeutics

NABRIVA THERAPEUTICS (NBRV) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be.....


NABRIVA THERAPEUTICS

Ticker: NBRV
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 353 16492000
Fax:
Address: 25-28 North Wall Quay
Dublin, 1 Ireland

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture